Phase 3 CAR-T Vs SOC In Relapse Refractory Multiple Myeloma

Discover how effective we are in immunophenotyping for a Car-T therapy take a look at this case study

Case Study – Phase 3 CAR-T vs SOC in Relapse Refractory Multiple Myeloma (RRMM)

Reach out to our experts and discover how we can help you advance your clinical trials